What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access. Today’s platforms and scientific advancements allow such optimizations, but ...

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a market size of USD 24.6 Billion by 2032 growing at a CAGR of 18.5% from ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced three presentations that underscore ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...

Curiel joked that a symposium on emerging nonviral vectors was a "failure" compared to other packed talks at the American Society of Gene Therapy's inaugural meeting last month. The director of the ...